Group 1 - The company will announce the implementation of equity distribution and the adjustment of the conversion price for "Aladdin Convertible Bonds" on May 29, 2025 [1] - From May 28, 2025, until the equity distribution registration date, the "Aladdin Convertible Bonds" will suspend conversion, and conversion will resume on the first trading day after the registration date [1] - The profit distribution plan for the year 2024 includes a cash dividend of 1 yuan (before tax) for every 10 shares and a capital reserve increase of 2 shares for every 10 shares [1]

Core Viewpoint - The peroxide industry in China has shown stable growth, driven by increasing demand from downstream sectors such as chemicals, plastics, rubber, and textiles, with the market size expected to reach 14.152 billion RMB in 2024 [1][9]. Industry Definition and Classification - Peroxides are compounds containing peroxide groups (-O-O-), characterized by their ability to form covalent bonds with other atoms or groups, leading to diverse structures and properties [2]. Industry Chain Overview - The peroxide industry chain includes upstream raw material supply, midstream production, and downstream applications. Upstream involves basic chemical raw materials like hydrogen and oxygen, while midstream focuses on the production processes. Downstream applications span various sectors, including chemical reactions, textile bleaching, and environmental treatment [4][5]. Development History - The Chinese peroxide industry has evolved over 70 years, transitioning from reliance on imports to developing a domestic production system. The industry has moved from a growth phase to an innovation stage, emphasizing technological advancements and integration into emerging sectors [6][9]. Current Market Analysis - The global peroxide market is projected to reach 40.757 billion RMB in 2024, with significant growth in the Asia-Pacific region, particularly in China, which is a major consumer and producer [8][9]. China's peroxide demand is expected to reach 1.15 million tons in 2024, reflecting a 6.8% year-on-year increase [12]. Key Enterprises in the Industry - Major players include: - **LUXI Chemical**: Dominates the industrial-grade hydrogen peroxide market with a focus on low-cost production [16]. - **Strong Functional Chemicals**: Specializes in organic peroxides, leveraging safety control technologies [16]. - **Yake Technology**: Focuses on electronic-grade hydrogen peroxide, achieving a purity of ≥99.999% [18]. - **Aladdin Biochemical**: Serves the research market with high-purity peroxide products [16]. - **Satellite Chemical**: Expands into hydrogen peroxide production using by-products from ethylene projects [16]. Future Development Trends - The industry is moving towards high-end products, driven by increasing performance requirements in sectors like electronics and pharmaceuticals [20]. - There is a strong emphasis on green and environmentally friendly production methods, with a focus on reducing pollution and developing biodegradable products [21]. - Strict safety regulations are shaping the industry, necessitating enhanced safety measures and management practices [22].

西部证券股份有限公司 关于上海阿拉丁生化科技股份有限公司 2024 年度持续督导跟踪报告 保荐人（主承销商） （陕西省西安市新城区东新街 319 号 8 幢 10000 室） 西部证券股份有限公司 关于上海阿拉丁生化科技股份有限公司 公司目前面临的风险因素主要如下： 2024 年度持续督导跟踪报告 西部证券股份有限公司（以下简称"西部证券"或"保荐人"）作为上海阿 拉丁生化科技股份有限公司（以下简称"阿拉丁"或"公司"）持续督导阶段的 保荐人，根据《证券发行上市保荐业务管理办法》（以下简称"保荐办法"）、 《上海证券交易所科创板股票上市规则》（以下简称"上市规则"）以及《科创 板上市公司持续监管办法（试行）》等相关规定，负责阿拉丁的持续督导工作， 并出具本持续督导年度跟踪报告。 一、持续督导工作情况 | 序号 | 工作内容 | 持续督导工作情况 | | --- | --- | --- | | | 建立健全并有效执行持续督导工作制度，并针对具 | 已建立健全并有效执行持续 督导工作制度，已根据公司的 | | 1 | | | | | 体的持续督导工作制定相应的工作计划。 | 具体情况制定了相应的工作 | | | ...

Group 1: Industry Overview - The petrochemical and chemical indices experienced a positive trend due to tariff policy impacts, with the chemical raw materials index rising by 1.30%, chemical machinery index by 0.12%, pharmaceutical index by 2.01%, and pesticide and fertilizer index by 1.28% [1] - In the oil sector, the oil processing index remained stable, while the oil extraction index increased by 0.64% and the oil trading index rose by 0.98% [1] - International crude oil prices fluctuated, with WTI settling at $62.49 per barrel, up 2.41% from May 9, and Brent at $65.41 per barrel, up 2.35% [1] Group 2: Market Performance - The top five performing listed chemical companies in the capital market included Yuzhong Three Gorges A, which rose by 50.65%, Jitai Co., up 47.10%, Suzhou Longjie, up 36.27%, ST Youfu, up 34.54%, and Hongqiang Co., up 33.55% [2] - The five companies with the largest declines were Aiai Precision Engineering, down 7.50%, Yongyue Technology, down 7.49%, Huate Gas, down 6.90%, Aladdin, down 6.88%, and Runbei Hangke, down 6.38% [2] Group 3: Product Price Changes - The top five petrochemical products with the highest price increases included butadiene, up 21.10%, SBS, up 13.65%, pure benzene, up 11.36%, styrene, up 10.43%, and PX, up 9.77% [1] - The five petrochemical products with the largest price declines were liquid chlorine, down 464.29%, trichloromethane, down 6.49%, yellow phosphorus, down 5.80%, vitamin VC, down 5.13%, and ethylene, down 3.53% [1]

Core Points - The annual general meeting of Shanghai Aladdin Biochemical Technology Co., Ltd. was held on May 15, 2025, with no rejected proposals [2] - All resolutions presented at the meeting were approved, including the annual reports and profit distribution plans [4][5][6] Meeting Details - The meeting took place at the company's office in Shanghai, with a combination of on-site and online voting methods [2] - The chairman, Mr. Xu Jiuzhen, presided over the meeting, ensuring compliance with relevant laws and regulations [2][3] Attendance - Out of 9 current directors, 7 attended the meeting, while all 3 supervisors were present [3] - The board secretary and all senior executives were also in attendance [3] Resolutions Passed - Key resolutions included the approval of the 2024 Board of Directors' work report, the 2024 Supervisory Board's work report, and the 2024 annual financial report [4][5] - The proposal for the 2025 financial budget and the reappointment of the auditing firm for 2025 were also approved [5][6] Legal Verification - The meeting was witnessed by lawyers from Shanghai Jintiancheng Law Firm, confirming that all procedures and resolutions were in accordance with the law [7] Management Appointment - On May 15, 2025, the board appointed Mr. Tan Xiaoyong as the vice president, effective immediately [8][9] - Mr. Tan holds 1,791,395 shares in the company and meets all qualifications for the position [10]

Core Viewpoint - Shanghai Aladdin Biochemical Technology Co., Ltd. has appointed Mr. Tan Xiaoyong as the Vice General Manager, effective from May 15, 2025, until the end of the current board term [1]. Group 1: Appointment Details - The appointment was approved during the 39th meeting of the fourth board of directors [1]. - Mr. Tan Xiaoyong holds 1,791,395 shares in the company and meets the qualifications required by relevant laws and regulations [2]. Group 2: Mr. Tan Xiaoyong's Background - Mr. Tan Xiaoyong, born in October 1984, is a Chinese national with a master's degree [4]. - His previous roles include positions in marketing and business development at various companies, and he has been involved in financial management and executive roles since 2020 [4].

| 证券代码：688179 证券简称：阿拉丁 公告编号：2025-038 | | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 转债代码：118006 转债简称：阿拉转债 | | | | | | | | | | | 上海阿拉丁生化科技股份有限公司 | | | | | | | | | | | 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 | | | | | | | | | | | 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 | | | | | | | | | | | 重要内容提示： | | | | | | | | | | | 本次会议是否有被否决议案：无 | ? | | | | | | | | | | 一、 会议召开和出席情况 | | | | | | | | | | | （一） 股东大会召开的时间：2025 | | 年 05 | 月 | 15 日 | | | | | | | （二） 股东大会召开的地点：上海市浦东新区新金桥路 | | | | | 36 | ...

上海市锦天城律师事务所 关于上海阿拉丁生化科技股份有限公司 法律意见书 地址：上海市浦东新区银城中路 501 号上海中心大厦 9、11、12 层 电话：021-20511000 传真：021-20511999 邮编：200120 上海市锦天城律师事务所 法律意见书 上海市锦天城律师事务所 关于上海阿拉丁生化科技股份有限公司 法律意见书 致：上海阿拉丁生化科技股份有限公司 上海市锦天城律师事务所（以下简称"本所"）接受上海阿拉丁生化科技股 份有限公司（以下简称"公司"）委托，就公司召开 2024 年年度股东大会（以下 简称"本次股东大会" ）的有关事宜，根据《中华人民共和国公司法》 （以下简称 "《公司法》"）、《上市公司股东大会规则》等法律、法规、规章和其他规范性文 件以及《上海阿拉丁生化科技股份有限公司章程》 （以下简称"《公司章程》"）的 有关规定，出具本法律意见书。 为出具本法律意见书，本所及本所律师依据《律师事务所从事证券法律业务 管理办法》和《律师事务所证券法律业务执业规则（试行）》等规定，严格履行 了法定职责，遵循了勤勉尽责和诚实信用原则，对本次股东大会所涉及的相关事 项进行了必要的核查和验证，核 ...

| 证券代码：688179 | 证券简称：阿拉丁 | 公告编号：2025-039 | | --- | --- | --- | | 转债代码：118006 | 转债简称：阿拉转债 | | 上海阿拉丁生化科技股份有限公司 关于聘任副总经理的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 2025 年 5 月 16 日 谭小勇，男，1984 年 10 月出生，中国国籍，无境外永久居留权，硕士研究 生学历。2008 年 2 月至 2009 年 3 月，任上海上体活力体育文化服务有限公司市 场推广；2009 年 4 月至 2009 年 8 月，任上海锐聪实验室设备有限公司业务员； 2010 年 11 月至 2019 年 11 月，任上海永叶生物科技有限公司执行董事兼总经理； 2011 年 11 月至 2019 年 8 月，任上海先浩国际贸易有限公司执行董事兼总经理； 2009 年 8 月至今，任上海源叶生物科技有限公司执行董事，总经理；2018 年 10 月至今，任北京源叶生物科技有限公司董事,财务负责人,经理；2020 年 ...

上海市锦天城律师事务所 关于上海阿拉丁生化科技股份有限公司 2024 年年度股东大会的 法律意见书 地址：上海市浦东新区银城中路 501 号上海中心大厦 9、11、12 层 上海市锦天城律师事务所（以下简称"本所"）接受上海阿拉丁生化科技股 份有限公司（以下简称"公司"）委托，就公司召开 2024 年年度股东大会（以下 简称"本次股东大会"）的有关事宜，根据《中华人民共和国公司法》（以下简称 "《公司法》"）、《上市公司股东大会规则》等法律、法规、规章和其他规范性文 件以及《上海阿拉丁生化科技股份有限公司章程》（以下简称"《公司章程》"）的 有关规定，出具本法律意见书。 电话：021-20511000 传真：021-20511999 邮编：200120 上海市锦天城律师事务所 法律意见书 上海市锦天城律师事务所 关于上海阿拉丁生化科技股份有限公司 2024 年年度股东大会的 法律意见书 致：上海阿拉丁生化科技股份有限公司 为出具本法律意见书，本所及本所律师依据《律师事务所从事证券法律业务 管理办法》和《律师事务所证券法律业务执业规则（试行）》等规定，严格履行 了法定职责，遵循了勤勉尽责和诚实信用原则，对本次股 ...